AI Update: SoftBank’s $40 Billion Investment in AI, Lilly’s $2.75 Billion Pharmaceutical Agreement, and Grok’s Challenges in the EU

SoftBank has secured a $40 billion short-term loan to support its increasing stake in OpenAI, indicating confidence in a potential IPO. Eli Lilly has entered into a $2.75 billion agreement with Insilico Medicine to market AI-created drugs worldwide. In Europe, Elon Musk’s Grok is encountering legal challenges due to the misuse of AI-generated images. Additionally, India’s Sarvam AI has introduced Chanakya for secure government implementations.